CClinicalTrials.gg
CompletedNCT00857740Updated Jul 8, 2010

Influence of Painphysiolgy Education on the Pain Inhibition in Fibromyalgia

An Early Phase 1 interventional study of Education in Fibromyalgia, sponsored by Vrije Universiteit Brussel. Completed at 1 site in Belgium. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2010-07-08.

Sponsored by Vrije Universiteit Brussel · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to investigate whether education about the neurophysiology of pain is able to improve central pain inhibition in patients with Fibromyalgia.

02

Conditions studied

03

In context

Fibromyalgia

1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.

This study's planned enrollment of 50 is below the median of 60 across 1,035 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Vrije Universiteit Brussel is the lead sponsor of 154 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Diagnose fibromyalgia
  • Widespread pain
  • Dutch speaking
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (estimated)

Interventions

  • BehavioralEducation

    Education about the neurophysiology of pain

06

What researchers measure

Primary outcomes

  1. Diffuse noxious inhibitory control

    Time frame: baseline, 14 days and 3 months follow-up

Secondary outcomes

  1. pain pressure thresholds

    Time frame: baseline, 14 days and 3 months follow-up

07

Study locations

1 site
  • Vrije Universiteit Brussel
    Brussels, 1500, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00857740
Lead sponsor
Vrije Universiteit Brussel
First posted
Mar 9, 2009
Start date
Mar 2009
Primary completion
Jun 2010
Completion
Jun 2010
Last update
Jul 8, 2010

Study contacts

Jessica Van Oosterwijck, Doctoranda
principal investigator · Vrije Universiteit Brussel
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion